Mehr lesen
Offering significant benefits to both healthcare providers and patients, telehealth is a key component in the future of urology and patient care. Telehealth in Urology is a step-by-step, illustrated guide for clinicians who are beginning a telehealth offering or are interested in adopting new digital technologies-all specific and relevant to today's urology practice. It covers the key information you need to know-from necessary equipment to the practice team-with clear explanations of how you can best use telemedicine to provide timely, effective care to every patient.
- Explains how to establish and conduct telehealth consultations and describes the growing number of options in telehealth diagnostics, patient monitoring, and digital therapeutics.
- Offers practical examples of conducting telehealth visits for common adult and pediatric urological complaints, for both benign and malignant conditions.
- Guides readers step by step through the many practical challenges of telemedicine for clinicians, patients, and practices, and describes the opportunities that lay ahead for the field.
- Covers regulatory, compliance, and technical principles of telehealth devices and applications for use in urology, including key topics such as data protection, patient privacy, e-prescribing, remote diagnostics and monitoring, and much more.
Über den Autor / die Autorin
Dara Lundon - Dr.Lundon MD MBA PhD is Director of Clinical Trials and Innovation at the Icahn School of Medicine at Mount Sinai New York. Dr. Lundon graduated from The School of Medicine at University College Dublin where he was admitted as an Entrance Scholar for outstanding academic achievement. He undertook his residency in Ireland and subsequently completed his Ph.D in Prostate Cancer Biology under the supervision of Professor R.W.G Watson and the late Professor John M. Fitzpatrick. Dr. Lundon received a scholarship to the NCI Cancer Prevention Program at the NIH in Bethesda MD and completed a fellowship in NYU under the supervision of Professor Stacy Loeb. Dr. Lundon completed an MBA and was an analyst on the number 1 ranked team on Wall Street in Large Cap Pharma, Biotech and Specialty Pharma. Prostate biopsy is an invasive procedure with a risk of significant morbidity. Dr. Lundon's clinical research work has translated discoveries from bench to bedside and helped reduce the number of unnecessary prostate biopsies in men
As well as other yet to be confirmed subject matter experts for each volume
